Cardiology Panel
The Cardiology Genetics Panel is an advanced diagnostic assay utilizing Next-Generation Sequencing (NGS) technology to simultaneously screen targeted genes associated with inherited cardiovascular conditions. Designed to uncover the molecular etiology of cardiomyopathies, channelopathies, and familial hypercholesterolemia, this panel identifies individuals at risk long before clinical symptoms manifest. It serves as a vital tool for stratifying sudden cardiac death (SCD) risk and formulating proactive family-centered care strategies.
Key Features & Advantages
- Precise Molecular Diagnosis: Confirms genetic etiologies in patients presenting with borderline, atypical, or overlapping cardiovascular phenotypes.
- Sudden Cardiac Death (SCD) Prevention: Uncovers occult arrhythmic and structural gene variants, particularly in young individuals and competitive athletes.
- Cascade Family Screening: Identifies pathogenic variants in the index patient (proband) to enable targeted, cost-effective screening for first-degree relatives.
- Genotype-Guided Clinical Management: Tailors pharmacotherapy, informs ICD (Implantable Cardioverter-Defibrillator) implantation decisions, and guides physical activity recommendations based on specific genotypes.
Cardiovascular Genetics Panel vs. Standard Cardiac Imaging/Diagnostics
| Feature | Cardiology Genetics Panel (NGS) | Conventional Cardiac Tests (ECHO, ECG, CT) |
| Diagnostic Level | Direct genomic variants and pathogenic mutations | Structural, functional, and electrical manifestations |
| Pre-Symptomatic Detection | Yes (Identifies risk decades before onset) | No (Detects changes only after tissue remodeling) |
| SCD Risk Stratification | Superior (Identifies high-risk arrhythmic variants) | Moderate (Evaluates current physiological risk) |
| Familial Risk Assessment | Yes (Determines inheritance patterns & cascade screening) | Limited (Evaluates individual phenotype only) |
| Therapeutic Precision | Genotype-specific targeted interventions | Symptom-driven standardized management |
Key Applications
- Inherited Cardiomyopathies: Diagnostic panels for Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), and Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC/D).
- Cardiac Channelopathies: Screening for Long QT Syndrome (LQTS), Brugada Syndrome, Short QT Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT).
- Aortic & Connective Tissue Disorders: Profiling Marfan Syndrome, Loeys-Dietz Syndrome, and Familial Thoracic Aortic Aneurysm and Dissection (TAAD).
- Familial Hypercholesterolemia (FH): Comprehensive screening of lipid metabolism genes (LDLR, APOB, PCSK9) to prevent premature coronary artery disease.
The Nucleus Genetics Advantage: Integrating comprehensive target enrichment panels with high sequence coverage and multidisciplinary curation by clinical geneticists and cardiologists, we transform complex genomic data into actionable cardiovascular insights.
Get Information About This Service
Our expert team is ready to answer your questions and offer tailored solutions.
Contact Form →